«Carbonic Anhydrase I

Below is an extended Carbonic Anhydrase I patents listing. Click here to return to the Carbonic Anhydrase I main in depth entry.

Patents :
US Patent No.	Title
5545304	Ion current detector for high pressure ion sources for monitoring separations
6335170	Gene expression in bladder tumors
6337195	Colon specific genes and proteins
6500920	Inhibitor of transforming growth factor .beta. and A method of inhibiting the biological effects of transforming growth factor
6638621	Coated particles, methods of making and using
6790657	Lentivirus vector system
6803203	DNA-PK assay
6831152	Colon specific genes and proteins
6931327	System and methods for processing analyte sensor data
6953658	Method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancer
6991809	Particles with improved solubilization capacity
6326161	Rapid motor for cancer diagnosis
6291247	Methods of screening for factors that disrupt neurotrophin conformation and reduce neurotrophin biological activity
6217860	Gene therapy for solid tumors, papillomas and warts
5631236	Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk
5676849	Method for enrichment of fetal cell population from maternal whole blood samples
5679582	Screening method for identifying ligands for target proteins
5906724	Apparatus for separation of nucleated blood cells from a blood sample
5948278	System and method for enrichment of rare cell population from whole blood samples
5972684	Carbonic anhydrase VIII
6025194	Nucleic acid sequence of senescence asssociated gene
6066624	Gene therapy for solid tumors using adenoviral vectors comprising suicide genes and cytokine genes
6069299	Fungus and insect control with chitinolytic enzymes
6210574	System for separation of nucleated fetal erythrocytes from maternal blood samples
7015210	Methods of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists
7022896	Methods and materials for making and using transgenic dicamba-degrading organisms
7276029	System and methods for processing analyte sensor data
7291461	Methods for identifying small molecules that modulate premature translation termination and nonsense mRNA decay
7300797	Lysis reagent for blood cell analysis
7310544	Methods and systems for inserting a transcutaneous analyte sensor
7329422	Pharmaceutical compositions
7364592	Biointerface membrane with macro-and micro-architecture
7366556	Dual electrode system for a continuous analyte sensor
7379765	Oxygen enhancing membrane systems for implantable devices
7381709	Method of expressing foreign gene in kidney
7402410	Humanized immunoglobulin reactive with .alpha.4.beta.7 integrin
7264926	Nucleoside Phosphatase
7256184	Treatment of aging disorders in humans
7226780	Lentivirus vector system
7060275	Use of protein biomolecular targets in the treatment and visualization of brain tumors
7074307	Electrode systems for electrochemical sensors
7105229	Coated particles, methods of making and using
7105724	Methods and materials for making and using transgenic dicamba-degrading organisms
7108778	Electrochemical sensors including electrode systems with increased oxygen generation
7112668	Polypeptides and nucleic acids encoded thereby
7134999	Optimized sensor geometry for an implantable glucose sensor
7147851	Humanized immunoglobulin reactive with .alpha.4.beta.7 integrin
7192450	Porous membranes for use with implantable devices
7217570	Organotypic intestinal culture and methods of use thereof
7424318	Dual electrode system for a continuous analyte sensor

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.